Brief: Argent Biopharma Names Igor Bluvstein As CFO
07/05/2024 07:27
May 7 (Reuters) - Argent BioPharma Ltd RGT.AX :
* ARGENT BIOPHARMA LTD - TRADING ON THE OTCQB AND
APPOINTMENT OF
CFO
* ARGENT BIOPHARMA LTD: APPOINTMENT OF IGOR BLUVSTEIN AS
CHIEF
FINANCIAL OFFICER
Source text for Eikon: ID:nRSG3880Na
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program